Louiser Upile Kalitera
Biographic Data
| ID | 9074459 |
|---|---|
| NAME | Louiser Upile Kalitera |
| GIVEN NAMES | Louiser Upile |
| FAMILY NAME | Kalitera |
| SIGNATURE | KALITERA L U |
| AFFILIATIONS | Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
Viral suppression (VS) in children has remained suboptimal compared to that in adults. We evaluated the impact of transitioning children weighing < 20 kg to a pediatric formulation of dolutegravir (pDTG) on VS in Malawi. We analyzed routine retrospective program data from electronic medical record systems pooled across 169 healthcare facilities in Malawi supported by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF). We included children who…
Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 Covid-19 Vaccines among Mobile Phone Users in Malawi
The safety profiles of the Ad26.COV2.S and AZD1222 COVID-19 vaccines have not been described in the general population in Malawi. We present self-reported adverse events (AE) following the receipt of these vaccines in Malawi as part of a national syndromic surveillance survey. We conducted phone-based syndromic surveillance surveys among adults (≥18 years) with verbal consent. We used secure tablets through random digit dialing to select mobile p…
No prominent works on this page.
Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 Covid-19 Vaccines among Mobile Phone Users in Malawi
The safety profiles of the Ad26.COV2.S and AZD1222 COVID-19 vaccines have not been described in the general population in Malawi. We present self-reported adverse events (AE) following the receipt of these vaccines in Malawi as part of a national syndromic surveillance survey. We conducted phone-based syndromic surveillance surveys among adults (≥18 years) with verbal consent. We used secure tablets through random digit dialing to select mobile p…
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
Viral suppression (VS) in children has remained suboptimal compared to that in adults. We evaluated the impact of transitioning children weighing < 20 kg to a pediatric formulation of dolutegravir (pDTG) on VS in Malawi. We analyzed routine retrospective program data from electronic medical record systems pooled across 169 healthcare facilities in Malawi supported by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF). We included children who…
Immunology (2 works) · Internal Medicine (2 works) · Logistic regression (2 works) · Medicine (2 works) · Odds (2 works) · Odds ratio (2 works) · Adverse effect (1 work) · Antiretroviral therapy (1 work) · COVID-19 epidemiological studies (1 work) · Demography (1 work)